Myomo (MYO) Asset Writedowns and Impairment (2017 - 2025)
Myomo (MYO) posted Asset Writedowns and Impairment of $103779.0 for Q3 2025, up 100.95% on a QoQ basis from $51643.0 in Q1 2025.
Myomo (MYO) Asset Writedowns and Impairment (2017 - 2025) Analysis & Trends
Myomo's Asset Writedowns and Impairment history runs 8 years deep, the most recent figure standing at $103779.0 for Q3 2025.
- Quarterly Asset Writedowns and Impairment changed N/A year-over-year to $103779.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $193822.0 (up 821.56% YoY) and the FY2024 annual result came in at $43657.0, up 53.72% from the prior year.
- Asset Writedowns and Impairment was $103779.0 for Q3 2025 at Myomo, up from $51643.0 in the prior quarter.
- Across five years, Asset Writedowns and Impairment topped out at $103779.0 in Q3 2025 and bottomed at -$374.0 in Q3 2023.
- A 4-year average of $31694.4 and a median of $20925.0 in 2022 frame the typical range for Asset Writedowns and Impairment.
- Annual changes were most pronounced in 2023 — Asset Writedowns and Impairment plunged 50.14% — and 2024, when it soared 143.42%.
- Myomo's Asset Writedowns and Impairment stood at $26075.0 in 2022, then sank by 39.5% to $15775.0 in 2023, then surged by 143.42% to $38400.0 in 2024, then jumped by 170.26% to $103779.0 in 2025.
- Business Quant data shows MYO's Asset Writedowns and Impairment at $103779.0 in Q3 2025, $51643.0 in Q1 2025, and $38400.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Myomo | 43.43 Mn | 24.46 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 103,779.00 |
| Sep 30, 2025 | 103,779.00 |
| Mar 31, 2025 | 51,643.00 |
| Mar 31, 2025 | 51,643.00 |
| Dec 31, 2024 | 38,400.00 |
| Dec 31, 2024 | 38,400.00 |
| Jun 30, 2024 | 5,257.00 |
| Jun 30, 2024 | 5,257.00 |
| Dec 31, 2023 | 15,775.00 |
| Dec 31, 2023 | 15,775.00 |
| Sep 30, 2023 | -374.00 |
| Sep 30, 2023 | -374.00 |
| Mar 31, 2023 | 13,000.00 |
| Mar 31, 2023 | 13,000.00 |
| Mar 31, 2022 | 26,075.00 |
| Mar 31, 2022 | 26,075.00 |
| Dec 31, 2020 | -20,000.00 |
| Dec 31, 2020 | -20,000.00 |
| Sep 30, 2020 | -16,000.00 |
| Sep 30, 2020 | -16,000.00 |